Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
46.09 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Amphastar Pharmaceuticals, Inc. |
Symbool | AMPH |
Munteenheid | USD |
Prijs | 46.09 |
Beurswaarde | 2,243,467,622 |
Dividendpercentage | 0% |
52-weken bereik | 36.56 - 65.92 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Yongfeng Zhang Ph.D. |
Website | https://www.amphastar.com |
An error occurred while fetching data.
Over Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)